Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Other Non-Current Liabilities (2023 - 2025)

Bioharvest Sciences has reported Other Non-Current Liabilities over the past 3 years, most recently at $2.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 629.04% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, up 629.04%, while the annual FY2025 figure was $2.0 million, 629.04% up from the prior year.
  • Other Non-Current Liabilities was $2.0 million for Q4 2025 at Bioharvest Sciences, down from $2.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $8.6 million in Q2 2024 and bottomed at $272000.0 in Q4 2024.
  • The 3-year median for Other Non-Current Liabilities is $2.0 million (2023), against an average of $3.1 million.
  • Year-over-year, Other Non-Current Liabilities crashed 86.14% in 2024 and then soared 629.04% in 2025.
  • Over 3 years, Other Non-Current Liabilities stood at $2.0 million in 2023, then crashed by 86.14% to $272000.0 in 2024, then soared by 629.04% to $2.0 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $2.0 million (Q4 2025), $2.0 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.